Latest Psychedelic News

Ibogaine and LSD Producer MindMed Applies for Nasdaq Up-Listing

Investor News

New York-based MindMed has applied for a Nasdaq up-listing and the company is valued at $190 million.

September 30, 2020
Jill Ettinger

Taking Psychedelics Mimics Religious Experiences

Science & Research

New data reveal that taking psychedelics may impact users in a way similar to having a mystical or religious experience.

September 29, 2020
Jill Ettinger

New Partnership Will Bring Quick Dissolve Strips To Psychedelics

Science & Research

Psychedelic drugs could soon have a standardized, and much faster delivery method with the announcement made from ATAI Life Sciences AG and IntelGenx.

September 23, 2020
New Partnership Will Bring Quick-Dissolve Strips to Psychedelics

Psychedelic Medicine Association Launches To Align The Industry

Science & Research

A first of its kind, The Psychedelic Medicine Association (PMA) is set to launch on September 29th.

September 23, 2020
Jill Ettinger

Why Investors Are Betting on Psychedelics

Investor News

Psychedelics are now bringing another long-term scenario: big-time investments. 

September 23, 2020
Jill Ettinger

Ann Arbor Michigan Decriminalizes Psychedelics

Psychedelic Reform

The Ann Arbor City Council voted this week to decriminalize psychedelic substances

September 23, 2020
Jill Ettinger

UC Berkeley launches new center for psychedelic science and education

Psychedelic Reform

With anonymous seed funding of $1.25 million, UC Berkeley will begin to conduct research using psychedelics to investigate cognition, perception, and emotion.

September 16, 2020
Yasmin Anwar

Could Group Therapy Make Psychedelic Drug Treatments More Accessible?

Psychedelic Reform

Older adults are now moving toward using psychedelics and cannabis as a way to treat illnesses at an affordable cost.

September 16, 2020
Abbie Rosner